John Thompson

Emeritus Professor of Melanoma & Surgical Oncology

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

ORCID

Google Scholar

About

John Thompson is an Emeritus Professor of Melanoma & Surgical Oncology at The University of Sydney, Australia. His research primarily focuses on melanoma treatment and outcomes, including multidisciplinary team discussions, sentinel node positivity, and the quality of life for melanoma patients. Recent publications include systematic reviews on Mohs micrographic surgery and the effects of smoking on melanoma incidence.

John Thompson

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Nodal radioactivity after lymphoscintigraphy as a guide to sentinel node–positivity in melanoma patients

Response to Han and Liu

Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

Management changes and survival outcomes for cancer patients after multidisciplinary team discussion; a systematic review and meta-analysis

Long-term survival across Breslow thickness categories: findings from a population-based study of 210 042 Australian melanoma patients

Knowledge of sentinel lymph node status improves accuracy when predicting melanoma mortality and selecting patients for adjuvant immunotherapy

Effect of smoking on melanoma incidence: a systematic review with meta-analysis

Mohs micrographic surgery for the treatment of invasive melanoma: A systematic review with meta‐analyses

Regarding sentinel lymph node biopsy in younger and older patients

Online tools for predicting melanoma survival: Including sentinel node status as a variable improves prediction accuracy

Outcomes for smokers who develop melanoma: a systematic review and meta-analysis

The association of dermatologist demographic density with melanoma survival in New South Wales, Australia

Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial

Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta‐analysis

Uncovering the complex relationship between balding, testosterone and skin cancers in men.

Response to ‘Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable’

Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics

Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites

Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?

Collaborators (15)

Caroline G. Watts

Jane Yuet Ching Hui

Alexander HR Varey

Anna Nowak

Iris Bartula

Serigne N. Lô

Micaela Hernberg

Anne E Cust

Jordan Conway

Stuart MacGregor

Bruce Armstrong

Jukka Pappinen

Richard A. Scolyer

Kerwin Shannon

Ines Pires da Silva

How do I reach out?

Meet Kite AI